bf/NASDAQ:VRTX_icon.jpeg

COM:VRTX

Vertex Pharmaceuticals Incorporated

  • Stock

USD

Last Close

450.37

22/11 21:00

Market Cap

126.86B

Beta: -

Volume Today

1.27M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-687.55M
-
-742.75M
8.03%
-588.18M
20.81%
-84.03M
85.71%
91.64M
209.05%
2.09B
2,177.63%
1.18B
43.62%
2.71B
130.42%
2.34B
13.63%
3.32B
41.84%
3.62B
8.96%
depreciation and amortization
48.37M
-
63.26M
30.79%
62.34M
1.44%
61.40M
1.52%
61.40M
0.00%
72.42M
17.95%
106.94M
47.67%
109.52M
2.41%
125.60M
14.69%
148.30M
18.07%
181.30M
22.25%
deferred income tax
-285.05M
-
281K
100.10%
3.28M
1,068.33%
16.96M
416.63%
-120.51M
810.53%
-1.51B
1,154.91%
167.39M
111.07%
277.34M
65.69%
-154.60M
155.74%
-275.90M
78.46%
-536.50M
94.45%
stock based compensation
127.30M
-
177.54M
39.46%
231.03M
30.12%
237.71M
2.89%
290.74M
22.31%
325.05M
11.80%
360.49M
10.90%
429.46M
19.13%
441.40M
2.78%
491.30M
11.30%
581.20M
18.30%
change in working capital
-5.05M
-
-11.06M
119.03%
-85.95M
676.91%
-2.07M
97.59%
15.26M
837.39%
238.02M
1,459.36%
-66.10M
127.77%
-54.45M
17.62%
-105.20M
93.19%
340.80M
423.95%
-265.70M
177.96%
accounts receivables
53.36M
-
7.43M
86.08%
-104.85M
1,511.51%
-33.03M
68.50%
-71.76M
117.27%
-108.15M
50.72%
-225.59M
108.58%
-223.44M
0.95%
-274.70M
22.94%
-358.60M
30.54%
-84.10M
76.55%
inventory
7.14M
-
-16.47M
330.59%
-23.15M
40.54%
-16.45M
28.93%
-44.98M
173.46%
-31.96M
28.94%
-64.05M
100.37%
-132.01M
106.12%
-92.80M
29.70%
-136.40M
46.98%
-322.90M
136.73%
accounts payables
-49.23M
-
25.05M
150.88%
-1.71M
106.82%
-11.74M
587.24%
8.75M
174.53%
36.55M
317.62%
-22.79M
162.33%
51.28M
325.04%
31.90M
37.79%
120.80M
278.68%
48.70M
59.69%
other working capital
-16.32M
-
-27.07M
65.85%
43.75M
261.63%
59.15M
35.20%
123.25M
108.37%
341.58M
177.14%
246.32M
27.89%
249.73M
1.38%
230.40M
7.74%
715M
210.33%
92.60M
87.05%
other non cash items
750.42M
-
-471K
100.06%
12.05M
2,657.96%
6.14M
49.04%
506.42M
8,147.93%
60.02M
88.15%
-176.20M
393.56%
-220.00M
24.86%
-5.80M
97.36%
103.40M
1,882.76%
-42.60M
141.20%
net cash provided by operating activities
-51.57M
-
-513.20M
895.15%
-365.43M
28.79%
236.10M
164.61%
844.94M
257.87%
1.27B
50.34%
1.57B
23.54%
3.25B
107.32%
2.64B
18.75%
4.13B
56.23%
3.54B
14.35%
investments in property plant and equipment
-51.39M
-
-51.20M
0.37%
-45.30M
11.52%
-56.56M
24.86%
-259.42M
358.64%
-95.52M
63.18%
-75.45M
21.01%
-259.80M
244.33%
-235M
9.55%
-204.70M
12.89%
-258.40M
26.23%
acquisitions net
-10M
-
-80M
700%
-160M
-
-1.15B
-
-418.24M
63.76%
77.00M
118.41%
-295.90M
484.29%
-6.10M
97.94%
purchases of investments
-2.41B
-
-1.42B
40.96%
-633.04M
55.55%
-629.70M
0.53%
-532.58M
15.42%
-515.39M
3.23%
-576.51M
11.86%
-450.72M
21.82%
-605.20M
34.27%
-740.50M
22.36%
-3.82B
415.53%
sales maturities of investments
2.35B
-
1.56B
33.66%
1.07B
31.48%
757.56M
29.03%
369.21M
51.26%
431.58M
16.89%
570.86M
32.27%
809.91M
41.88%
499.30M
38.35%
920M
84.26%
934.20M
1.54%
other investing activites
61.39M
-
1.39M
97.73%
-40.24M
2,986.94%
33.17M
182.42%
145.11M
337.46%
-22.82M
115.73%
418.24M
-
-77.00M
118.41%
6.10M
-
net cash used for investing activites
-54.13M
-
73.96M
236.63%
268.86M
263.52%
104.47M
61.14%
-437.68M
518.96%
-202.16M
53.81%
-1.24B
511.07%
99.39M
108.05%
-340.90M
443.00%
-321.10M
5.81%
-3.14B
878.42%
debt repayment
-83.74M
-
-81.69M
2.45%
-20.34M
75.11%
-93.03M
357.48%
-319.34M
243.27%
-33.39M
89.54%
-39.19M
17.36%
-42.27M
7.89%
-47M
11.18%
-85.50M
81.91%
-44.90M
47.49%
common stock issued
265.88M
-
274.62M
3.29%
185.59M
32.42%
68.23M
63.24%
344.84M
405.41%
289.29M
16.11%
343.24M
18.65%
264.95M
22.81%
102M
61.50%
186.30M
82.65%
134.60M
27.75%
common stock repurchased
-350.04M
-
-192.01M
45.15%
-739.41M
285.08%
-1.56B
111.16%
-172M
88.98%
-427.60M
148.60%
dividends paid
-20.84M
-
-10.05M
51.79%
-264.95M
2,537.33%
-102M
61.50%
other financing activites
-1.25M
-
304.45M
24,417.33%
23.66M
92.23%
158.07M
568.03%
42.90M
72.86%
43.76M
2.00%
24.77M
43.38%
276.40M
1,015.64%
130.30M
52.86%
3.50M
97.31%
-224.30M
6,508.57%
net cash used provided by financing activities
180.88M
-
497.38M
174.97%
188.92M
62.02%
133.27M
29.46%
68.40M
48.67%
-71.22M
204.12%
126.77M
278.00%
-505.28M
498.57%
-1.48B
192.51%
-67.70M
95.42%
-562.20M
730.43%
effect of forex changes on cash
4.71M
-
-2.18M
146.22%
-2.83M
30.24%
-4.67M
64.64%
5.80M
224.35%
-6.18M
206.55%
1.64M
126.58%
20.55M
1,150.88%
-13.40M
165.20%
-29.20M
117.91%
26.90M
192.12%
net change in cash
79.89M
-
55.96M
29.96%
89.51M
59.95%
469.18M
424.17%
481.47M
2.62%
990.73M
105.77%
462.43M
53.32%
2.87B
520.24%
811.20M
71.72%
3.71B
357.58%
-139.70M
103.76%
cash at beginning of period
489.41M
-
569.30M
16.32%
625.26M
9.83%
714.77M
14.32%
1.18B
65.64%
1.67B
40.84%
2.66B
59.41%
3.12B
17.40%
5.99B
91.91%
6.80B
13.55%
10.51B
54.59%
cash at end of period
569.30M
-
625.26M
9.83%
714.77M
14.32%
1.18B
65.64%
1.67B
40.67%
2.66B
59.62%
3.12B
17.40%
5.99B
91.91%
6.80B
13.55%
10.51B
54.59%
10.37B
1.33%
operating cash flow
-60.67M
-
-573.11M
844.70%
-365.43M
36.24%
236.10M
164.61%
844.94M
257.87%
1.27B
50.34%
1.57B
23.54%
3.25B
107.32%
2.64B
18.75%
4.13B
56.23%
3.54B
14.35%
capital expenditure
-51.39M
-
-51.20M
0.37%
-45.30M
11.52%
-56.56M
24.86%
-259.42M
358.64%
-95.52M
63.18%
-75.45M
21.01%
-259.80M
244.33%
-235M
9.55%
-204.70M
12.89%
-258.40M
26.23%
free cash flow
-170.49M
-
-624.31M
266.19%
-410.73M
34.21%
179.54M
143.71%
745.52M
315.24%
1.17B
57.58%
1.49B
27.16%
2.99B
100.40%
2.41B
19.55%
3.93B
62.97%
3.28B
16.47%

All numbers in USD (except ratios and percentages)